Nuvectis Pharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology. Its product pipeline includes NXP800 and NXP900. The company was founded by Ronald E. Bentsur, Enrique Poradosu, and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
13
Frequently Asked Questions
What is Market Cap of Nuvectis Pharma Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Nuvectis Pharma Inc market cap is $162.92M.
What is the 52-week high for Nuvectis Pharma Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Nuvectis Pharma Inc 52 week high is $11.80 as of September 09, 2025.
What is the 52-week low for Nuvectis Pharma Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Nuvectis Pharma Inc 52 week low is $4.44 as of September 09, 2025.
What is Nuvectis Pharma Inc stock price today?
Nuvectis Pharma Inc stock price today is $6.34.
What was Nuvectis Pharma Inc stock price yesterday?
Nuvectis Pharma Inc stock price yesterday was $6.40.
What is the PE ratio of Nuvectis Pharma Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Nuvectis Pharma Inc’s P/E ratio is -5.69.
What is the Price-to-Book ratio of Nuvectis Pharma Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Nuvectis Pharma Inc P/B ratio is 9.0575.
What is the 50-day moving average of Nuvectis Pharma Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Nuvectis Pharma Inc 50-day moving average is $7.12.